Natural history of herpes zoster: Late follow-up of 3.9 years (n = 43) and 7.7 years (n = 10)-Reference-Cited by-同舟云学术

Natural history of herpes zoster: Late follow-up of 3.9 years (n = 43) and 7.7 years (n = 10)

Published:2013-10 Issue:10 Volume:154 Page:2227-2233
ISSN:0304-3959
Container-title:Pain
language:en
Short-container-title:

Author:

Reda Haatem,Greene Kaitlin,Rice Frank L.,Rowbotham Michael C.,Petersen Karin L.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Anesthesiology and Pain Medicine,Neurology (clinical),Neurology

Reference31 articles.

1. Patient perspective on herpes zoster and its complications: an observational prospective study in patients aged over 50 years in general practice.;Bouhassira;PAIN,2012

2. Development of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: adaptation of the brief pain inventory.;Coplan;J Pain,2004

3. A prospective study of the herpes zoster severity of illness.;Drolet;Clin J Pain,2010

4. Predictors of postherpetic neuralgia among patients with herpes zoster: a prospective study.;Drolet;J Pain,2010

5. Pain and its persistence in herpes zoster.;Dworkin;PAIN,1996

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mucocutaneous Pain Syndromes;Rook's Textbook of Dermatology;2024-03-19

2. Evaluation of the correlation of dorsal root ganglia and spinal nerves with clinical symptoms in patients with postherpetic neuralgia using magnetic resonance neurography;PeerJ;2023-08-31

3. Cutaneous nerve fiber and peripheral Nav1.7 assessment in a large cohort of patients with postherpetic neuralgia;Pain;2023-06-27

4. Comparison of Adjuvant Hypertonic Saline and Normal Saline for Epidural Block in Patients with Postherpetic Neuralgia: A Double-Blind, Randomized Trial;Pain Research and Management;2022-11-21

5. Dermatopharmacokinetic and pharmacodynamic evaluation of a novel nanostructured formulation containing capsaicinoids for treating neuropathic pain;International Journal of Pharmaceutics;2021-03